Anaphylaxis: statement on initial management in nonhospital settings. Laboratory Centre for Disease Control.
D000293:Adolescent; D000367:Age Factors; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy*; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004155:Diphenhydramine / Q000627:therapeutic use; D004630:Emergencies; D004837:Epinephrine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D014612:Vaccines / Q000009:adverse effects*
D018926:Anti-Allergic Agents; D001993:Bronchodilator Agents; D014612:Vaccines; D004155:Diphenhydramine; D004837:Epinephrine